Clinical trial
Multiple Biomarkers in Undiagnosed Pleural Effusion
NCT00316134 · Fujirebio Diagnostics, Inc., Industry · Terminated
Key facts
| NCT number | NCT00316134 |
|---|---|
| Title | Multiple Biomarkers in Undiagnosed Pleural Effusion |
| Official title | Evaluation of Multiple Biomarkers in Serum and Pleural Fluid to Estimate the Probability of Cancer in Patients Presenting With an Undiagnosed Pleural Effusion |
| Lead sponsor | Fujirebio Diagnostics, Inc., Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Pleural Effusion, Malignant |
| Intervention type | Procedure |
| Interventions | Procedure/Surgery |
| Enrollment | 200 |
| Start date | Mar 1, 2006 |
| Completion | Feb 1, 2008 |
| First posted | Apr 20, 2006 |
| Last update posted | Nov 8, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: